FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Bipartisan Bill to Expand Diagnostic Testing

[ Price : $8.95]

Bipartisan legislation is introduced to speed lab test development and approval.

Purple Book Enhancements in First Phase

[ Price : $8.95]

Federal Register notice: FDA announces the completion of the first phase of its enhanced Purple Book for biologics.

Public Meeting on Device User Fee Reauthorization

[ Price : $8.95]

FDA announces a 4/7 public meeting on reauthorizing the Medical Device User Fee Amendments for fiscal years 2023 through 2027.

Hahn Updates FDA Actions on CBD

[ Price : $8.95]

FDA commissioner Stephen Hahn updates agency education, data-gathering, and enforcement actions for CBD products.

Coronavirus Test Goal Wont be Met: Pence

[ Price : $8.95]

Vice president Mike Pence admits that the government will not meet its projected goal of delivering one million coronavirus tests ...

FDA Bans Some Electrical Stimulation Devices

[ Price : $8.95]

FDA publishes a final rule banning electrical stimulation devices for self-injurious or aggressive behavior.

Deemed to be a License Questions, Answers

[ Price : $8.95]

FDA publishes a question-and-answer guidance on the transition provision of the Biologics Price Competition and Innovation Act und...

Info Collection on GMPs for Medicated Feeds

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension for medicated feed GMPs.

Regulatory Review Period for Kyowa Asthma Drug

[ Price : $8.95]

Federal Register notice: FDA determines the regulatory review period for patent extension purposes for Kyowa Hakko Kirins Fasenra ...

Guide on Contacts Performance Criteria

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Soft (Hydrophilic) Daily Wear Contact Lenses Performance C...